ArticleOncology letters2018

Therapeutic effects of lenvatinib in combination with rAd-p53 for the treatment of non-small cell lung cancer.

Renzhi Yu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.